{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:01:59Z","timestamp":1789628519692,"version":"build-2803163510"},"reference-count":43,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2026.2969","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T07:02:19Z","timestamp":1785999739000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["AXL is associated with STAT3 activation in breast cancer"],"prefix":"10.3892","volume":"25","author":[{"given":"Guoan","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Forensic Medicine, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobai","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, Jinan Vocational College of Nursing, Jinan, Shandong 250102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Liangshan People's Hospital, Jining, Shandong 272600, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaozhen","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Forensic Medicine, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlin","family":"Luan","sequence":"additional","affiliation":[{"name":"School of Forensic Medicine, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Forensic Medicine, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Guan","sequence":"additional","affiliation":[{"name":"School of Forensic Medicine, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Forensic Medicine, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Hu","sequence":"additional","affiliation":[{"name":"School of Forensic Medicine, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Forensic Medicine, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"E.","sequence":"additional","affiliation":[{"name":"School of Forensic Medicine, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Xiong","sequence":"additional","affiliation":[{"name":"School of Forensic Medicine, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junze","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Forensic Medicine, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Hu","sequence":"additional","affiliation":[{"name":"School of Mental Health (Research Institute of Mental Health), Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Mental Health (Research Institute of Mental Health), Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyao","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Mental Health (Research Institute of Mental Health), Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Digestive Diseases Hospital of Shandong First Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, and Department of Child Health, Jinan Children's Hospital, Jinan, Shandong 250022, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"key20260917090401_b1-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20260917090401_b2-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"66","key":"key20260917090401_b3-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"156338","key":"key20260917090401_b4-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156338","article-title":"The advancements in targeted therapeutic strategies for breast cancer via intervention of natural molecules: An insight into cellular and molecular mechanisms","volume":"278","author":"Kaleem","year":"2026","journal-title":"Pathol Res Pract"},{"issue":"155800","key":"key20260917090401_b5-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155800","article-title":"Novel therapeutic approaches targeting cancer stem cells: Unveiling new frontiers in breast cancer treatment","volume":"266","author":"Deeptha","year":"2025","journal-title":"Pathol Res Pract"},{"issue":"148","key":"key20260917090401_b6-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02726-w","article-title":"AXL in cancer: A modulator of drug resistance and therapeutic target","volume":"42","author":"Tang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"key20260917090401_b7-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02210-9","article-title":"AXL: Shapers of tumor progression and immunosuppressive microenvironments","volume":"24","author":"Liu","year":"2025","journal-title":"Mol Cancer"},{"issue":"153","key":"key20260917090401_b8-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1090-3","article-title":"AXL receptor tyrosine kinase as a promising anti-cancer approach: Functions, molecular mechanisms and clinical applications","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol Cancer"},{"issue":"156120","key":"key20260917090401_b9-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156120","article-title":"AXL in cardiovascular diseases: Pathophysiological insights and clinical perspectives","volume":"272","author":"Qian","year":"2025","journal-title":"Pathol Res Pract"},{"key":"key20260917090401_b10-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1073\/pnas.0909333107","article-title":"Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival","volume":"107","author":"Gjerdrum","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"448","key":"key20260917090401_b11-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2023.12147","article-title":"Triple-negative breast cancer cells that survive ionizing radiation exhibit an Axl-dependent aggressive radioresistant phenotype","volume":"26","author":"Ji","year":"2023","journal-title":"Exp Ther Med"},{"issue":"749","key":"key20260917090401_b12-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.13010","article-title":"Anti-Axl monoclonal antibodies attenuate the migration of MDA-MB-231 breast cancer cells","volume":"22","author":"Chang","year":"2021","journal-title":"Oncol Lett"},{"key":"key20260917090401_b13-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.3892\/ol.2017.7694","article-title":"Function of Axl receptor tyrosine kinase in non-small cell lung cancer","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol Lett"},{"issue":"37","key":"key20260917090401_b14-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02121-7","article-title":"AXL signaling in cancer: From molecular insights to targeted therapies","volume":"10","author":"Yadav","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"key20260917090401_b15-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1158\/0008-5472.CAN-24-3841","article-title":"AXL tyrosine kinases: A growing isoform family that promotes cancer pathogenesis","volume":"85","author":"Eriksen Gjerstad","year":"2025","journal-title":"Cancer Res"},{"key":"key20260917090401_b16-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"48","key":"key20260917090401_b17-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5636","article-title":"Role of STAT3 in cancer cell epithelial-mesenchymal transition (review)","volume":"64","author":"Zhang","year":"2024","journal-title":"Int J Oncol"},{"issue":"33","key":"key20260917090401_b18-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-0527-z","article-title":"Role of STAT3 signaling pathway in breast cancer","volume":"18","author":"Ma","year":"2020","journal-title":"Cell Commun Signal"},{"issue":"195","key":"key20260917090401_b19-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: A systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"ra66","key":"key20260917090401_b20-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004155","article-title":"The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells","volume":"6","author":"Meyer","year":"2013","journal-title":"Sci Signal"},{"key":"key20260917090401_b21-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.3892\/ol.2017.7443","article-title":"AXL is a marker for epithelial-mesenchymal transition in esophageal squamous cell carcinoma","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol Lett"},{"issue":"e202000985","key":"key20260917090401_b22-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202000985","article-title":"The AXL-PYK2-PKC\u03b1 axis as a nexus of stemness circuits in TNBC","volume":"4","author":"Khera","year":"2021","journal-title":"Life Sci Alliance"},{"key":"key20260917090401_b23-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41416-025-03218-8","article-title":"Cancer-associated fibroblast-derived GAS6 increases resistance to chemotherapy through AXL\/STAT3\/ABCG1 in gastric cancer","volume":"134","author":"Kim","year":"2026","journal-title":"Br J Cancer"},{"issue":"113067","key":"key20260917090401_b24-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113067","article-title":"AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages","volume":"42","author":"Hung","year":"2023","journal-title":"Cell Rep"},{"issue":"22","key":"key20260917090401_b25-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2023.2618","article-title":"AXL upregulates c-Myc expression through AKT and ERK signaling pathways in breast cancers","volume":"18","author":"Sun","year":"2023","journal-title":"Mol Clin Oncol"},{"issue":"41","key":"key20260917090401_b26-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9169","article-title":"Pharmaceutical inhibition of AXL suppresses tumor growth and invasion of esophageal squamous cell carcinoma","volume":"20","author":"Han","year":"2020","journal-title":"Exp Ther Med"},{"key":"key20260917090401_b27-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"e0184372","key":"key20260917090401_b28-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184372","article-title":"Validation of the 18-gene classifier as a prognostic biomarker of distant metastasis in breast cancer","volume":"12","author":"Cheng","year":"2017","journal-title":"PLoS One"},{"key":"key20260917090401_b29-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1158\/1078-0432.CCR-07-1833","article-title":"A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer","volume":"14","author":"Chanrion","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20260917090401_b30-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis","volume":"47 (W1)","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"key20260917090401_b31-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jds.2023.08.014","article-title":"Nuclear translocation of Axl contributes to the malignancy of oral cancer cells","volume":"19","author":"Su","year":"2024","journal-title":"J Dent Sci"},{"issue":"23","key":"key20260917090401_b32-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-02949-5","article-title":"Unraveling the complexity of STAT3 in cancer: Molecular understanding and drug discovery","volume":"43","author":"Hu","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"key20260917090401_b33-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrclinonc.2009.129","article-title":"Src kinases as therapeutic targets for cancer","volume":"6","author":"Kim","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"key20260917090401_b34-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1101\/gad.351985.124","article-title":"Fatty acid uptake activates an AXL-CAV1-\u03b2-catenin axis to drive melanoma progression","volume":"39","author":"Chocarro-Calvo","year":"2025","journal-title":"Genes Dev"},{"key":"key20260917090401_b35-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41417-020-0163-1","article-title":"Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6\/AXL\/SRC signaling","volume":"27","author":"Dong","year":"2020","journal-title":"Cancer Gene Ther"},{"key":"key20260917090401_b36-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1158\/0008-5472.CAN-19-1366","article-title":"S100A10 is a critical mediator of GAS6\/AXL-induced angiogenesis in renal cell carcinoma","volume":"79","author":"Xiao","year":"2019","journal-title":"Cancer Res"},{"key":"key20260917090401_b37-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/ijc.29923","article-title":"Constitutive activation of STAT3 in breast cancer cells: A review","volume":"138","author":"Banerjee","year":"2016","journal-title":"Int J Cancer"},{"key":"key20260917090401_b38-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/1535-7163.MCT-22-0617","article-title":"Therapeutic landscape of AXL receptor kinase in triple-negative breast cancer","volume":"22","author":"Ozyurt","year":"2023","journal-title":"Mol Cancer Ther"},{"issue":"106057","key":"key20260917090401_b39-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.106057","article-title":"Accelerating AXL targeting for TNBC therapy","volume":"139","author":"Khera","year":"2021","journal-title":"Int J Biochem Cell Biol"},{"issue":"247","key":"key20260917090401_b40-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010247","article-title":"AXL controls directed migration of mesenchymal triple-negative breast cancer cells","volume":"9","author":"Zajac","year":"2020","journal-title":"Cells"},{"key":"key20260917090401_b41-MCO-25-4-02969","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1158\/0008-5472.CAN-09-2997","article-title":"R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer","volume":"70","author":"Holland","year":"2010","journal-title":"Cancer Res"},{"issue":"2846","key":"key20260917090401_b42-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58179-6","article-title":"Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: A phase 1b\/2a trial","volume":"16","author":"Loges","year":"2025","journal-title":"Nat Commun"},{"issue":"100554","key":"key20260917090401_b43-MCO-25-4-02969","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100554","article-title":"AXL targeting restores PD-1 blockade sensitivity of STK11\/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells","volume":"3","author":"Li","year":"2022","journal-title":"Cell Rep Med"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:04:09Z","timestamp":1789625049000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2026.2969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,6]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2026.2969","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}